SEC Comment Letter for AVANIR PHARMACEUTICALS (CIK 0000858803) — May 26, 2005

AVANIR PHARMACEUTICALS (CIK 0000858803)
Date: May 26, 2005 · CIK: 0000858803 · Accession: 0000000000-05-026179

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 001-15803

Date

May 26, 2005

Author

Joel Parker

Form

UPLOAD

Company

AVANIR PHARMACEUTICALS (CIK 0000858803)

Letter

Via Facsimile and U.S. Mail Mail Stop 6010 May 26, 2005 Mr. Gregory P. Hanson Chief Financial Officer Avanir Pharmaceuticals 11388 Sorrento Valley Road San Diego, CA 92121

Re: Avanir Pharmaceuticals Form 10-K for the fiscal year ended September 30, 2004 Filed December 14, 2004 File No. 001-15803

Dear Mr. Hanson,

We have completed our review of your Form 10-K and related filings and have no further comments at this time.

Sincerely,
Joel Parker
Accounting Branch Chief

Show Raw Text

<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>

Via Facsimile and U.S. Mail
Mail Stop 6010

May 26, 2005

Mr. Gregory P. Hanson
Chief Financial Officer
Avanir Pharmaceuticals
11388 Sorrento Valley Road
San Diego, CA 92121

Re:	Avanir Pharmaceuticals
      Form 10-K for the fiscal year ended September 30, 2004
      Filed December 14, 2004
      File No. 001-15803

Dear Mr. Hanson,

      We have completed our review of your Form 10-K and related
filings and have no further comments at this time.

						Sincerely,

								Joel Parker
								Accounting Branch Chief

</TEXT>
</DOCUMENT>

SecProbe.io